ENDRA Life Sciences Inc. (NDRA) |
|
0.7515 -0.028 (-3.63%)
|
09-20 19:27 |
|
Open: |
0.77 |
Pre. Close: |
0.7798 |
|
High:
|
0.79 |
Low:
|
0.7463 |
|
Volume:
|
116,206 |
Market Cap:
|
16M |
|
|
|
|
ENDRA Life Sciences, Inc. develops medical imaging technology. The company is headquartered in Ann Arbor, Michigan and currently employs 5 full-time employees. The firm's Nexus 128 system combines light-based thermoacoustics and ultrasound, to address the imaging needs of researchers studying disease models in pre-clinical applications. The firm is involved in developing Thermo Acoustic Enhanced Ultrasound (TAEUS) for incorporation into new ultrasound systems. The TAEUS platform has capabilities and potential clinical applications, such as enabling ultrasound to distinguish fat from lean tissue; enabling traditional ultrasound to visualize changes in tissue temperature, in real time; enabling ultrasound to view blood vessels from any angle, using only a saline solution contrasting agent, unlike Doppler ultrasound which requires precise viewing angles, and enabling ultrasound to image blood flow at the capillary level in a region, organ or tissue. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
0.79 - 0.796 |
0.796 - 0.8 |
|
Low:
|
0.74 - 0.745 |
0.745 - 0.749 |
|
Close:
|
0.743 - 0.751 |
0.751 - 0.758 |
|
Technical analysis |
as of: 2020-09-18 4:33:42 PM |
|
Overall:
|
  |
| Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected. |
| Target: |
Six months:  One year: 1.12 |
| Support: |
Support1: 0.70 Support2: 0.58 |
| Resistance: |
Resistance1: 0.86 Resistance2: 0.96 |
| Pivot: |
0.79 |
| Moving Average: |
MA(5): 0.78 MA(20): 0.81
MA(100): 0.88 MA(250): 1.04 |
| MACD: |
MACD(12,26): -0.04 Signal(9): -0.04 |
| Stochastic oscillator: |
%K(14,3): 47.05 %D(3): 49.14 |
| RSI: |
RSI(14): 35.07 |
| 52-week: |
High: 2.25 Low: 0.60 Change(%): -51.1 |
| Average Vol(K): |
3-Month: 44454 10-Days: 11870 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.NDRA has closed above bottom band by 13.5%. Bollinger Bands are 49.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to NDRA's normal range. The bands have been in this narrow range for 3 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
Tue, 15 Sep 2020
ENDRA Life Sciences : to Attend Lake Street's Fourth Annual Best Ideas Growth (BIG4) Conference September 17, 2020 - marketscreener.com
Mon, 14 Sep 2020
ENDRA Life Sciences to Present at the H.C. Wainwright 22nd Annual Global Investment Conference on September 16, 2020 - Yahoo Finance
Tue, 08 Sep 2020
How Should Investors React To ENDRA Life Sciences' (NASDAQ:NDRA) CEO Pay? - Yahoo Finance
Wed, 02 Sep 2020
ENDRA Life Sciences to Present at the LD Micro 500 Virtual Conference - Yahoo Finance
Thu, 27 Aug 2020
ENDRA Life Sciences to showcase TAEUS(R) Technology at EASL International Liver Congress 2020 - BioSpace
Thu, 27 Aug 2020
What’s The Key Support Level On ENDRA Life Sciences Inc. (NDRA)? - Invest Million
|
Financial Analysis |
| Growth |
n/a |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
n/a |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
n/a |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
n/a |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Underperform |
Price to Earnings: |
Underperform |
| Return on Equity: |
Underperform |
Debt to Equity: |
Outperform |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Diagnostics & Research |
| Shares Out. (M) |
21 |
| Shares Float (M) |
18 |
|
% Held by Insiders
|
3.45 |
|
% Held by Institutions
|
8.87 |
|
Shares Short (K)
|
596 |
|
Shares Short P. Month (K)
|
567 |
Stock Financials |
|
EPS
|
-1.745 |
|
EPS Est This Year
|
|
|
EPS Est Next Year
|
|
|
Book Value (p.s.)
|
0.060 |
|
Profit Margin
|
|
|
Operating Margin
|
|
|
Return on Assets (ttm)
|
-242.9 |
|
Return on Equity (ttm)
|
-1030.9 |
|
Qtrly Rev. Growth
|
|
|
Gross Profit (p.s.)
|
|
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
-0.557 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-11 |
|
Levered Free Cash Flow (M)
|
-6 |
Stock Valuations |
|
PE Ratio
|
-0.43 |
|
PEG Ratio
|
|
|
Price to Book value
|
12.53 |
|
Price to Sales
|
|
|
Price to Cash Flow
|
-1.44 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
